by in
Entry Author Date Location
OncoGenex’s Long Wait For Cancer Drug Ends With a Phase 3 Stumble 04/28/14 Seattle
Drug Development 101: A Story About OncoGenex and the FDA 02/26/14 Seattle
OncoGenex CFO Resigns After Developing Personal Relationship With CEO 02/04/13 Seattle
OncoGenex Waits, and Waits, For Data on Prostate Cancer Drug 08/02/12 Seattle
OncoGenex Snags $50M for Prostate Cancer Drug Plan 03/16/12 Seattle
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up 03/08/12 Seattle
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation 01/27/12 Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Dendreon’s Blow-Up, Epigenomics Leaves Town, Presage Adds $1.5M, & More Seattle-Area Life Sciences News 08/11/11 Seattle
OncoGenex Drops on Trial Delay 08/05/11 Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News 11/11/10 Seattle
OncoGenex Hires Burris 11/08/10 Seattle
Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News 10/21/10 Seattle
OncoGenex Raises $50M 10/19/10 Seattle
Mersana Strikes Deal With Teva Worth up to $334M for Long-Lasting Cancer Drug 04/13/10 Boston
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News 03/25/10 Seattle
OncoGenex Adds New Chairman 03/24/10 Seattle
Dendreon’s False Rumor, Cell Therapeutics’ New FDA Day, Microsoft’s Health-IT Plan, & More Seattle-Area Life Sciences News 03/04/10 Seattle
OncoGenex CFO Exits 02/25/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
Zulily Gets Funded, Ontela Merges with Photobucket, OncoGenex Secures $60M from Teva, & More Seattle-Area Deals News 12/22/09 Seattle
Isis Nabs $10M from OncoGenex Deal 12/21/09 San Diego
OncoGenex Grabs $60M Upfront From Teva for Rights to Cancer Drug, Shares Drop Anyway 12/21/09 Seattle
From Russia With Love (for Biotech), Stewart Parker Gets “Antsy” to Return 12/14/09 Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 09/22/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News 08/06/09 Seattle
OncoGenex, Toiling in Dendreon’s Shadow, Scopes Out Partners For Prostate Cancer Drug 08/05/09 Seattle
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News 07/23/09 Seattle
OncoGenex Raises $9.5M 07/20/09 Seattle
Page 1 of 2 next page »